Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cerebrum: Anatomical Overview I01:26

Cerebrum: Anatomical Overview I

The main and largest component of the human brain is the cerebrum. The cerebrum consists of two main parts: the cerebral cortex, an outer layer with wrinkles or folds known as gyri and shallow grooves called sulci, and a deeper region beneath it. The cerebrum divides into two distinct hemispheres and contains five different lobes: the frontal, parietal, temporal, occipital, and insula. The central sulcus separates the frontal and parietal lobes and two functionally important gyri — the...
Cerebellum: Anatomical Regions01:17

Cerebellum: Anatomical Regions

The cerebellum, also known as the "little brain," is located in the posterior cranial fossa, inferior to the tentorium cerebelli and dorsal to the brainstem. It plays a significant role in motor control, coordination, and proprioception.
Cerebellar Structure
Externally, the cerebellum features a highly convoluted surface with numerous folia (narrow ridges) separated by shallow sulci (grooves). The cerebellum is divided into two hemispheres by a thin median structure known as the vermis. The...
Glial Cells01:04

Glial Cells

Overview
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cerebrum: Anatomical Overview II01:11

Cerebrum: Anatomical Overview II

Each cerebral hemisphere can be divided into three main regions. The outermost region, the cerebral cortex, is a thin layer (2 to 4 millimeters thick) made up of gray matter, consisting of neuron cell bodies, dendrites, glial cells, and blood vessels. The middle region, or white matter, is primarily composed of myelinated nerve fibers organized into three types of large tracts: association fibers, commissures, and projection fibers. Association fibers connect different areas within the same...
Nervous Tissue: Glial Cells01:31

Nervous Tissue: Glial Cells

Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial cells that interact...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAR-T cell-associated neurotoxicity during therapy of hematologic malignancies: incidence, clinical features, predictive biomarkers and management measures.

Leukemia & lymphoma·2025
Same author

Imaging of Lymphomas Involving the CNS: An Update-Review of the Full Spectrum of Disease with an Emphasis on the World Health Organization Classifications of CNS Tumors 2021 and Hematolymphoid Tumors 2022.

AJNR. American journal of neuroradiology·2023
Same author

Diffuse Large B-Cell Epstein-Barr Virus-Positive Primary CNS Lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics.

AJNR. American journal of neuroradiology·2022
Same author

Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity.

Journal of neurology·2022
Same author

Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same author

Shifts in learning assistants' self-determination due to COVID-19 disruptions in Calculus II course delivery.

International journal of STEM education·2021

Related Experiment Video

Updated: Jun 12, 2026

Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe
06:04

Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe

Published on: August 16, 2024

[Gliomatosis cerebri].

J Bruna, R Velasco

    Neurologia (Barcelona, Spain)
    |May 25, 2010
    PubMed
    Summary

    Gliomatosis cerebri (GC) treatment shows improved responses with chemotherapy addition, but patient outcomes remain poor. Further multi-center trials and molecular factor identification are crucial for better gliomatosis cerebri patient stratification and treatment.

    Area of Science:

    • Neuro-oncology
    • Neurosurgery
    • Pathology

    Background:

    • Gliomatosis cerebri (GC) is a rare, diffuse glial tumor with extensive brain infiltration.
    • The heterogeneity in histological subtypes and grades presents diagnostic and therapeutic challenges.
    • Current understanding of GC is limited, with many unanswered questions regarding its nature and management.

    Discussion:

    • GC's non-specific clinical presentation and wide differential diagnosis complicate early identification.
    • Heterogeneity in pathology and molecular findings hinders accurate GC characterization and outcome prediction.
    • Therapeutic strategies for GC are primarily based on case series, indicating a lack of established optimal treatment protocols.

    Key Insights:

    • Adding chemotherapy to radiotherapy appears to improve treatment response in gliomatosis cerebri patients.

    More Related Videos

    Use of Cerebral Open-Flow Microperfusion for the Longitudinal Collection of Interstitial Fluid in an Animal Model of Glioblastoma
    08:50

    Use of Cerebral Open-Flow Microperfusion for the Longitudinal Collection of Interstitial Fluid in an Animal Model of Glioblastoma

    Published on: December 23, 2025

    Translational Orthotopic Models of Glioblastoma Multiforme
    07:37

    Translational Orthotopic Models of Glioblastoma Multiforme

    Published on: February 17, 2023

    Related Experiment Videos

    Last Updated: Jun 12, 2026

    Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe
    06:04

    Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe

    Published on: August 16, 2024

    Use of Cerebral Open-Flow Microperfusion for the Longitudinal Collection of Interstitial Fluid in an Animal Model of Glioblastoma
    08:50

    Use of Cerebral Open-Flow Microperfusion for the Longitudinal Collection of Interstitial Fluid in an Animal Model of Glioblastoma

    Published on: December 23, 2025

    Translational Orthotopic Models of Glioblastoma Multiforme
    07:37

    Translational Orthotopic Models of Glioblastoma Multiforme

    Published on: February 17, 2023

  • Despite treatment advancements, gliomatosis cerebri patients exhibit poor survival rates.
  • Identifying molecular predictors for chemotherapy response is a key area of ongoing research.
  • Outlook:

    • Phase III multi-center trials are essential to evaluate and establish optimal therapeutic strategies for GC.
    • Further research into the histological profile and molecular prognostic factors of GC is required.
    • Stratifying patients based on identified prognostic factors is crucial for personalized treatment approaches.